Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Anna Rizzi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Anatomy
Concepts & Ideas
Procedures
Phenomena
Physiology
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
63
Regoli, Domenico
48
Guerrini, Remo
42
Salvadori, Severo
22
Bigoni, Raffaella
21
Calo', Girolamo
20
Calò, Girolamo
19
Calo, Girolamo
17
Marzola, Giuliano
15
Camarda, Valeria
12
Lambert, David
11
Trapella, Claudio
9
Rizzi, Daniela
8
Bianchi, Clementina
7
Marzola, Erika
6
Varani, Katia
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Anna Rizzi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Trapella Claudio; Fischetti Carmela; Pela' Michela; Lazzari Ilaria; Guerrini Remo; Calo' Girolamo; Rizzi Anna; Camarda Valeria; Lambert David G; McDonald John; Regoli Domenico; Salvadori Severo
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.
Bioorganic & medicinal chemistry 2009;17(14):5080-95.
-
2009: Guerrini Remo; Camarda Valeria; Trapella Claudio; Caló Girolamo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.
Journal of medicinal chemistry 2009;52(13):4068-71.
-
2009: Fischetti Carmela; Camarda Valeria; Rizzi Anna; Pelà Michela; Trapella Claudio; Guerrini Remo; McDonald John; Lambert David G; Salvadori Severo; Regoli Domenico; Calo' Girolamo
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.
European journal of pharmacology 2009;614(1-3):50-7.
-
2009: Fischetti Carmela; Rizzi Anna; Gavioli Elaine C; Marzola Giuliano; Trapella Claudio; Guerrini Remo; Petersen Jorgen S; Calo Girolamo
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
Peptides 2009;30(2):248-55.
-
2009: Camarda Valeria; Rizzi Anna; Ruzza Chiara; Zucchini Silvia; Marzola Giuliano; Marzola Erika; Guerrini Remo; Salvadori Severo; Reinscheid Rainer K; Regoli Domenico; Calò Girolamo
In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
The Journal of pharmacology and experimental therapeutics 2009;328(2):549-55.
-
2009: Guerrini Remo; Camarda Valeria; Trapella Claudio; Calò Girolamo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.
Journal of medicinal chemistry 2009;52(2):524-9.
-
2008: Camarda Valeria; Trapella Claudio; Calo' Girolamo; Guerrini Remo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Structure-activity study at positions 3 and 4 of human neuropeptide S.
Bioorganic & medicinal chemistry 2008;16(19):8841-5.
-
2008: Rizzi A; Vergura R; Marzola G; Ruzza C; Guerrini R; Salvadori S; Regoli D; Calo G
Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice.
British journal of pharmacology 2008;154(2):471-9.
-
2008: Camarda Valeria; Trapella Claudio; Calo Girolamo; Guerrini Remo; Rizzi Anna; Ruzza Chiara; Fiorini Stella; Marzola Erika; Reinscheid Rainer K; Regoli Domenico; Salvadori Severo
Synthesis and biological activity of human neuropeptide S analogues modified in position 2.
Journal of medicinal chemistry 2008;51(3):655-8.
-
2007: Rizzi Anna; Spagnolo Barbara; Wainford Richard D; Fischetti Carmela; Guerrini Remo; Marzola Giuliano; Baldisserotto Anna; Salvadori Severo; Regoli Domenico; Kapusta Daniel R; Calo Girolamo
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
Peptides 2007;28(6):1240-51.
-
2007: Gavioli Elaine C; Rizzi Anna; Marzola Giuliano; Zucchini Silvia; Regoli Domenico; Calo' Girolamo
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice.
Peptides 2007;28(6):1229-39.
-
2007: Spagnolo Barbara; Carrà Giacomo; Fantin Martina; Fischetti Carmela; Hebbes Chris; McDonald John; Barnes Timothy A; Rizzi Anna; Trapella Claudio; Fanton Giulia; Morari Michele; Lambert Dave G; Regoli Domenico; Calò Girolamo
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
The Journal of pharmacology and experimental therapeutics 2007;321(3):961-7.
-
2007: Rizzi Anna; Gavioli Elaine C; Marzola Giuliano; Spagnolo Barbara; Zucchini Silvia; Ciccocioppo Roberto; Trapella Claudio; Regoli Domenico; Calò Girolamo
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies.
The Journal of pharmacology and experimental therapeutics 2007;321(3):968-74.
-
2007: Nazzaro Cristiano; Rizzi Anna; Salvadori Severo; Guerrini Remo; Regoli Domenico; Zeilhofer Hanns Ulrich; Calo Girolamo
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
Peptides 2007;28(3):663-9.
-
2006: Rizzi Anna; Nazzaro Cristiano; Marzola G Giuliano; Zucchini Silvia; Trapella Claudio; Guerrini Remo; Zeilhofer Hanns Ulrich; Regoli Domenico; Calo' Girolamo
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
Pain 2006;124(1-2):100-8.
-
2006: Roth Adelheid L; Marzola Erika; Rizzi Anna; Arduin Marika; Trapella Claudio; Corti Corrado; Vergura Raffaella; Martinelli Prisca; Salvadori Severo; Regoli Domenico; Corsi Mauro; Cavanni Paolo; Caló Girolamo; Guerrini Remo
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation.
The Journal of biological chemistry 2006;281(30):20809-16.
-
2006: Gündüz Ozge; Rizzi Anna; Baldisserotto Anna; Guerrini Remo; Spagnolo Barbara; Gavioli Elaine C; Kocsis László; Magyar Anna; Benyhe Sándor; Borsodi Anna; Calò Girolamo
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.
European journal of pharmacology 2006;539(1-2):39-48.
-
2005: Carrà Giacomo; Rizzi Anna; Guerrini Remo; Barnes Timothy A; McDonald John; Hebbes Christopher P; Mela Flora; Kenigs Velga A; Marzola Giuliano; Rizzi Daniela; Gavioli Elaine; Zucchini Silvia; Regoli Domenico; Morari Michele; Salvadori Severo; Rowbotham David J; Lambert David G; Kapusta Daniel R; Calo' Girolamo
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
The Journal of pharmacology and experimental therapeutics 2005;312(3):1114-23.
-
2005: Guerrini Remo; Camarda Valeria; Marzola Erika; Arduin Marika; Calo Girolamo; Spagnol Martina; Rizzi Anna; Salvadori Severo; Regoli Domenico
Structure-activity relationship study on human urotensin II.
Journal of peptide science : an official publication of the European Peptide Society 2005;11(2):85-90.
-
2005: Calo Girolamo; Guerrini Remo; Rizzi Anna; Salvadori Severo; Burmeister Melissa; Kapusta Daniel R; Lambert David G; Regoli Domenico
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.
CNS drug reviews 2005;11(2):97-112.
-
2004: Vergura Raffaella; Camarda Valeria; Rizzi Anna; Spagnol Martina; Guerrini Remo; Calo' Girolamo; Salvadori Severo; Regoli Domenico
Urotensin II stimulates plasma extravasation in mice via UT receptor activation.
Naunyn-Schmiedeberg's archives of pharmacology 2004;370(5):347-52.
-
2004: Marti Matteo; Mela Flora; Veronesi Carlo; Guerrini Remo; Salvadori Severo; Federici Mauro; Mercuri Nicola B; Rizzi Anna; Franchi Gianfranco; Beani Lorenzo; Bianchi Clementina; Morari Michele
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(30):6659-66.
-
2002: Rizzi Anna; Rizzi Daniela; Marzola Giuliano; Regoli Domenico; Larsen Bjarne Due; Petersen Jorgen Soberg; Calo' Girolamo
Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.
British journal of pharmacology 2002;137(3):369-74.
-
2002: Camarda Valeria; Guerrini Remo; Kostenis Evi; Rizzi Anna; Calò Girolamo; Hattenberger Almut; Zucchini Marina; Salvadori Severo; Regoli Domenico
A new ligand for the urotensin II receptor.
British journal of pharmacology 2002;137(3):311-4.
-
2002: Rizzi Anna; Salis Maria Bonaria; Ciccocioppo Roberto; Marzola Giuliano; Bigoni Raffaella; Guerrini Remo; Massi Maurizio; Madeddu Paolo; Salvadori Severo; Regoli Domenico; Calo' Girolamo
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(6):450-6.
-
2002: Bigoni Raffaella; Rizzi Daniela; Rizzi Anna; Camarda Valeria; Guerrini Remo; Lambert David G; Hashiba Eiji; Berger Hartmut; Salvadori Severo; Regoli Domenico; Calo' Girolamo
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(6):442-9.
-
2002: Camarda V; Rizzi A; Calo G; Guerrini R; Salvadori S; Regoli D
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family.
Life sciences 2002;71(4):363-70.
-
2002: Bigoni R; Caò G; Rizzi A; Okawa H; Regoli D; Smart D; Lambert D G
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors.
Canadian journal of physiology and pharmacology 2002;80(5):407-12.
-
2002: Calo Girolamo; Rizzi Anna; Rizzi Daniela; Bigoni Raffaella; Guerrini Remo; Marzola Giuliano; Marti Matteo; McDonald John; Morari Michele; Lambert David G; Salvadori Severo; Regoli Domenico
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
British journal of pharmacology 2002;136(2):303-11.
-
2002: Camarda V; Rizzi A; Calo G; Wirth K; Regoli D
Pharmacological characterisation of novel kinin B2 receptor ligands.
Canadian journal of physiology and pharmacology 2002;80(4):281-6.
-
2002: Calo' Girolamo; Rizzi Anna; Bigoni Raffaella; Guerrini Remo; Salvadori Severo; Regoli Domenico
Pharmacological profile of nociceptin/orphanin FQ receptors.
Clinical and experimental pharmacology & physiology 2002;29(3):223-8.
-
2002: Camarda Valeria; Rizzi Anna; Calò Girolamo; Gendron Gabrielle; Perron Stephan I; Kostenis Evi; Zamboni Paolo; Mascoli Francesco; Regoli Domenico
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(2):141-9.
-
2002: Rizzi Daniela; Rizzi Anna; Bigoni Raffaella; Camarda Valeria; Marzola Giuliano; Guerrini Remo; De Risi Carmela; Regoli Domenico; Calo' Girolamo
[Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
The Journal of pharmacology and experimental therapeutics 2002;300(1):57-63.
-
2001: Guerrini R; Caló G; Bigoni R; Rizzi D; Rizzi A; Zucchini M; Varani K; Hashiba E; Lambert D G; Toth G; Borea P A; Salvadori S; Regoli D
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor.
Journal of medicinal chemistry 2001;44(23):3956-64.
-
2001: Rizzi A; Marzola G; Bigoni R; Guerrini R; Salvadori S; Mogil J S; Regoli D; Calò G
Endogenous nociceptin signaling and stress-induced analgesia.
Neuroreport 2001;12(14):3009-13.
-
2001: Rizzi D; Bigoni R; Rizzi A; Jenck F; Wichmann J; Guerrini R; Regoli D; Calo G
Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(5):551-5.
-
2001: Rizzi A; Bigoni R; Marzola G; Guerrini R; Salvadori S; Regoli D; Calo' G
Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(2):161-5.
-
2000: Bigoni R; Rizzi A; Rizzi D; Becker J A; Kieffer B L; Simonin F; Regoli D; Calo G
In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
Life sciences 2000;68(2):233-9.
-
2000: Quartara L; Ricci R; Meini S; Patacchini R; Giolitti A; Amadesi S; Rizzi C; Rizzi A; Varani K; Borea P A; Maggi C A; Regoli D
Ala scan analogues of HOE 140. Synthesis and biological activities.
European journal of medicinal chemistry 2000;35(11):1001-10.
-
2000: Rizzi A; Bigoni R; Marzola G; Guerrini R; Salvadori S; Regoli D; Calo G
The nociceptin/orphanin FQ receptor antagonist, [Nphe1]NC(1-13)NH2, potentiates morphine analgesia.
Neuroreport 2000;11(11):2369-72.
-
2000: Calo' G; Bigoni R; Rizzi A; Guerrini R; Salvadori S; Regoli D
Nociceptin/orphanin FQ receptor ligands.
Peptides 2000;21(7):935-47.
-
2000: Guerrini R; Calo' G; Rizzi A; Bigoni R; Rizzi D; Regoli D; Salvadori S
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A.
Peptides 2000;21(7):923-33.
-
2000: Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert D G; Borea P A; Tomatis R; Salvadori S; Regoli D
Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
Journal of medicinal chemistry 2000;43(15):2805-13.
-
2000: Bigoni R; Calo' G; Rizzi A; Guerrini R; De Risi C; Hashimoto Y; Hashiba E; Lambert D G; Regoli D
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(5):565-8.
-
2000: Calo' G; Guerrini R; Rizzi A; Salvadori S; Regoli D
Pharmacology of nociceptin and its receptor: a novel therapeutic target.
British journal of pharmacology 2000;129(7):1261-83.
-
2000: Calo' G; Guerrini R; Bigoni R; Rizzi A; Marzola G; Okawa H; Bianchi C; Lambert D G; Salvadori S; Regoli D
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.
British journal of pharmacology 2000;129(6):1183-93.
-
1999: Rizzi C; Rizzi A; Calò G; Jorizzo G; Agnello G; Mollica G; Inamura N; Regoli D
Characterization of FR 172357, a new non-peptide bradykinin B(2) receptor antagonist, in human, pig and rabbit preparations.
European journal of pharmacology 1999;386(1):25-31.
-
1999: Rizzi A; Bigoni R; Caló G; Guerrini R; Salvadori S; Regoli D
[Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon.
European journal of pharmacology 1999;385(2-3):R3-5.
-
1999: Rizzi A; Rizzi C; Amadesi S; Calo' G; Varani K; Inamura N; Regoli D
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(4):361-7.
-
1999: Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea P A; Regoli D
Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(3):270-7.
-
1999: Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi C A
MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
The Journal of pharmacology and experimental therapeutics 1999;289(3):1250-6.
-
1999: Bigoni R; Giuliani S; Calo' G; Rizzi A; Guerrini R; Salvadori S; Regoli D; Maggi C A
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(3):160-7.
-
1999: Rizzi A; Calò G; Trevisani M; Tognetto M; Fabbri L; Mapp C; Guerrini R; Salvadori S; Regoli D; Geppetti P
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus.
Life sciences 1999;64(13):PL157-63.
-
1998: Varani K; Calo G; Rizzi A; Merighi S; Toth G; Guerrini R; Salvadori S; Borea P A; Regoli D
Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships.
British journal of pharmacology 1998;125(7):1485-90.
-
1998: Rizzi A; Quaglio D; Vasquez G; Mascoli F; Amadesi S; Calò G; Regoli D; Zamboni P
Effects of vasoactive agents in healthy and diseased human saphenous veins.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 1998;28(5):855-61.
-
1998: Calò G; Rizzi A; Marzola G; Guerrini R; Salvadori S; Beani L; Regoli D; Bianchi C
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay.
British journal of pharmacology 1998;125(2):373-8.
-
1998: Calo' G; Guerrini R; Bigoni R; Rizzi A; Bianchi C; Regoli D; Salvadori S
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.
Journal of medicinal chemistry 1998;41(18):3360-6.
-
1998: Guerrini R; Calo G; Rizzi A; Bigoni R; Bianchi C; Salvadori S; Regoli D
A new selective antagonist of the nociceptin receptor.
British journal of pharmacology 1998;123(2):163-5.
-
1997: Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea P A; Regoli D
Human vascular kinin receptors of the B2 type characterized by radioligand binding.
British journal of pharmacology 1997;122(7):1450-4.
-
1997: Rizzi A; Calò G; Amadesi S; Regoli D
Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(5):662-70.
-
1997: Regoli D; Rizzi A; Calò G
Pharmacology of the kallikrein-kinin system.
Pharmacological research : the official journal of the Italian Pharmacological Society 1997;35(6):513-5.
-
1997: Calò G; Rizzi A; Bodin M; Neugebauer W; Salvadori S; Guerrini R; Bianchi C; Regoli D
Pharmacological characterization of nociceptin receptor: an in vitro study.
Canadian journal of physiology and pharmacology 1997;75(6):713-8.
-
1997: Rizzi A; Gobeil F; Bogoni G; Calò G; Campobasso C; Inamura N; Regoli D
Antagonistic effects of FR 173657 on human, pig, rabbit, and guinea pig kinin receptors: an in vitro study.
Canadian journal of physiology and pharmacology 1997;75(6):601-8.
-
1997: Guerrini R; Calo G; Rizzi A; Bianchi C; Lazarus L H; Salvadori S; Temussi P A; Regoli D
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide.
Journal of medicinal chemistry 1997;40(12):1789-93.
-
1997: Rizzi A; Gobeil F; Calò G; Inamura N; Regoli D
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study.
Hypertension 1997;29(4):951-6.
-
1997: Calò G; Rizzi A; Traina L; Regoli D
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
Life sciences 1997;60(4-5):PL63-8.
-
1996: Bogoni G; Rizzi A; Calo G; Campobasso C; D'Orleans-Juste P; Regoli D
Characterization of endothelin receptors in the human umbilical artery and vein.
British journal of pharmacology 1996;119(8):1600-4.
-
1996: Calò G; Rizzi A; Bogoni G; Neugebauer V; Salvadori S; Guerrini R; Bianchi C; Regoli D
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.
European journal of pharmacology 1996;311(1):R3-5.
-
1996: Regoli D; Calo G; Rizzi A; Bogoni G; Gobeil F; Campobasso C; Mollica G; Beani L
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors).
Regulatory peptides 1996;65(1):83-9.
-
1996: Gobeil F; Pheng L H; Badini I; Nguyen-Le X K; Pizard A; Rizzi A; Blouin D; Regoli D
Receptors for kinins in the human isolated umbilical vein.
British journal of pharmacology 1996;118(2):289-94.
Sign-in to see more
